PMC:7029759 / 824-983 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7029759","sourcedb":"PMC","sourceid":"7029759","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7029759","text":" new and effective therapies in this outbreak. I consider the options of drug repurposing, developing neutralizing monoclonal antibody therapy, and an oligonuc","tracks":[{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T23","span":{"begin":73,"end":77},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T22","span":{"begin":126,"end":134},"obj":"GO:0042571"}],"attributes":[{"subj":"T23","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T22","pred":"source","obj":"LitCovid-PMC-OGER-BB"}]},{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":126,"end":134},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62871"},{"subj":"T1","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":73,"end":77},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"subj":"T1","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PMC-OGER-BB","color":"#93c5ec","default":true},{"id":"LitCovid-PD-FMA-UBERON","color":"#dfec93"},{"id":"LitCovid-PD-CHEBI","color":"#de93ec"}]}]}}